Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Danish (OMX) Market Analysis & Valuation

UpdatedJan 16, 2026
DataAggregated Company Financials
Companies134
  • 7D0.6%
  • 3M9.6%
  • 1Y-16.7%
  • YTD6.1%

In the last week, the market has stayed flat, however the Real Estate sector stood out, gaining 3.6%. As for last year, the market is down 17%. Looking forward, earnings are forecast to grow by 6.1% annually.

Trending IndustriesBiotech

Market Valuation and Performance

Has the Danish Market valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Fri, 16 Jan 2026DKK 4.4tDKK 2.0tDKK 261.2b17x17x2.3x
Sun, 14 Dec 2025DKK 4.1tDKK 1.9tDKK 260.6b15x15.9x2.1x
Tue, 11 Nov 2025DKK 3.9tDKK 2.0tDKK 260.9b15.2x14.9x2x
Thu, 09 Oct 2025DKK 4.1tDKK 1.9tDKK 287.8b15.1x14.4x2.1x
Sat, 06 Sep 2025DKK 4.0tDKK 1.9tDKK 287.3b15.1x13.9x2.1x
Mon, 04 Aug 2025DKK 3.8tDKK 1.9tDKK 261.9b15.4x14.4x2x
Wed, 02 Jul 2025DKK 4.4tDKK 1.9tDKK 261.5b15.5x16.7x2.4x
Fri, 30 May 2025DKK 4.5tDKK 1.9tDKK 263.6b15.9x17.1x2.4x
Sun, 27 Apr 2025DKK 4.1tDKK 1.9tDKK 258.9b14.1x15.9x2.2x
Tue, 25 Mar 2025DKK 4.8tDKK 1.9tDKK 260.7b15.2x18.4x2.5x
Thu, 20 Feb 2025DKK 5.2tDKK 1.9tDKK 263.6b14.1x19.6x2.7x
Sat, 18 Jan 2025DKK 5.0tDKK 1.8tDKK 238.9b13.8x21x2.7x
Mon, 16 Dec 2024DKK 5.9tDKK 1.8tDKK 238.0b14x24.6x3.2x
Wed, 13 Nov 2024DKK 5.8tDKK 1.8tDKK 236.1b14.6x24.7x3.2x
Fri, 11 Oct 2024DKK 6.2tDKK 1.7tDKK 180.3b15.4x34.2x3.5x
Sun, 08 Sep 2024DKK 6.5tDKK 1.7tDKK 180.2b15.2x35.8x3.7x
Tue, 06 Aug 2024DKK 6.2tDKK 1.7tDKK 185.4b15.1x33.6x3.6x
Thu, 04 Jul 2024DKK 6.9tDKK 1.7tDKK 184.7b15.4x37.1x4x
Sat, 01 Jun 2024DKK 6.7tDKK 1.7tDKK 184.5b15.3x36.3x3.9x
Mon, 29 Apr 2024DKK 6.4tDKK 1.7tDKK 191.3b15x33.5x3.7x
Wed, 27 Mar 2024DKK 6.5tDKK 1.7tDKK 192.2b15.5x33.7x3.8x
Fri, 23 Feb 2024DKK 6.3tDKK 1.7tDKK 190.6b14.4x33.1x3.7x
Sun, 21 Jan 2024DKK 5.7tDKK 1.8tDKK 217.0b13.4x26.3x3.2x
Tue, 19 Dec 2023DKK 5.3tDKK 1.8tDKK 216.7b13.3x24.7x3x
Thu, 16 Nov 2023DKK 5.3tDKK 1.8tDKK 217.4b12.4x24.3x3x
Sat, 14 Oct 2023DKK 5.5tDKK 1.9tDKK 285.8b13x19.3x2.9x
Mon, 11 Sep 2023DKK 5.4tDKK 1.9tDKK 283.2b13.4x19.1x2.9x
Wed, 09 Aug 2023DKK 5.4tDKK 1.9tDKK 274.9b13.5x19.7x2.9x
Fri, 07 Jul 2023DKK 5.0tDKK 1.9tDKK 323.0b13.7x15.5x2.6x
Sun, 04 Jun 2023DKK 5.1tDKK 1.9tDKK 325.7b14.5x15.6x2.6x
Tue, 02 May 2023DKK 5.2tDKK 1.9tDKK 340.5b15.4x15.2x2.7x
Thu, 30 Mar 2023DKK 4.9tDKK 1.9tDKK 345.5b14.1x14.1x2.5x
Sat, 25 Feb 2023DKK 4.8tDKK 1.9tDKK 350.1b14.1x13.6x2.5x
Mon, 23 Jan 2023DKK 4.7tDKK 1.9tDKK 355.3b13.7x13.1x2.4x
Price to Earnings Ratio

13.1x


Total Market Cap: DKK 4.7tTotal Earnings: DKK 355.3bTotal Revenue: DKK 1.9tTotal Market Cap vs Earnings and Revenue0%0%0%
Danish Market Price to Earnings3Y Average 22.2x202420252026
Current Market PE
  • Investors are pessimistic on the Danish market, indicating that they anticipate earnings will not grow as fast as they have historically.
  • The market is trading at a PE ratio of 17.0x which is lower than its 3-year average PE of 22.2x.
Past Earnings Growth
  • The earnings for Danish listed companies have declined 9.8% per year over the last three years.
  • Meanwhile revenues have been flat.
  • This means that either the cost of doing business or the level of investment back into businesses is increasing since sales have remained steady while profits have fallen.

Sector Trends

Which sectors have driven the changes within the Danish Market?

DK Market0.57%
Real Estate3.56%
Materials3.12%
Financials2.87%
Industrials2.70%
Consumer Staples1.83%
Utilities1.04%
Telecom-0.28%
Energy-0.58%
Healthcare-0.90%
Tech-3.01%
Consumer Discretionary-12.45%
Sector PE
  • Investors favour the Tech sector the most for future growth, which is trading close to its 3-year average PE ratio of 52.2x.
    • The market's confidence is likely because analysts are expecting annual earnings growth of 57.0% which is higher than its past year's earnings decline of 17.5% per year.
Forecasted Growth
  • Analysts are most optimistic on the Tech sector, expecting annual earnings growth of 57% over the next 5 years.
  • This is better than its past earnings decline of 17% per year.
  • In contrast, the Energy sector is expected to see its earnings decline by 35% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuationSector
DSV DSVDKK 1.78k6.6%
+DKK 26.0b		22.5%PE44.3xIndustrials
DANSKE Danske BankDKK 323.502.9%
+DKK 7.3b		51.8%PB1.5xFinancials
NSIS B NovozymesDKK 422.103.1%
+DKK 5.9b		4.6%PE48.1xMaterials
VWS Vestas Wind SystemsDKK 186.102.7%
+DKK 4.9b		96.1%PE26.3xIndustrials
JYSK Jyske BankDKK 948.007.6%
+DKK 3.9b		79.2%PB1.1xFinancials
See more

Market Insights

Header cover image
Why Didn’t Oil React to Venezuela? 🇻🇪
Maduro is out, the US stepped in… and oil markets barely reacted? Let’s look at why.
Continue reading
Which Markets Will Sink or Swim in 2026? 🌍
Last Week

Which Markets Will Sink or Swim in 2026? 🌍

Latest News

NOVO B
DKK 365.20
Novo Nordisk
7D
-1.4%
1Y
-39.3%
JYSK
DKK 948.00
Jyske Bank
7D
7.6%
1Y
79.2%
PNDORA
DKK 545.80
Pandora
7D
-19.3%
1Y
-57.0%
MATAS
DKK 99.20
Matas
7D
-20.8%
1Y
-26.2%
DSV
DKK 1,778.00
DSV
7D
6.6%
1Y
22.5%

DSV: Margin Discipline And Freight Cycle Trends Will Shape Future Upside Potential

Analysts have nudged their fair value estimate for DSV higher from DKK 1,805.61 to DKK 1,825.84, reflecting recent price target increases from several firms and updated views on transport cycle trends and future P/E assumptions. Analyst Commentary Recent price target moves around DSV point to a generally constructive stance, with some caution around the freight cycle and earnings visibility.
ALK B
DKK 222.80
ALK-Abelló
7D
-2.4%
1Y
47.9%

ALK B: Future Returns Will Reflect Upgraded Outlook And Balanced Margin Prospects

Analysts have trimmed their price target for ALK-Abelló to €214.00 from €219.33, citing updated assumptions that now reflect slightly higher revenue growth, a modestly lower profit margin outlook and a small adjustment to the projected future P/E multiple. What's in the News ALK-Abelló upgraded its earnings guidance for the full year 2025, with expected revenue growth of 13% to 15% in local currencies, compared with a previous range of 12% to 14% (Key Developments).
FLS
DKK 515.00
FLSmidth
7D
8.5%
1Y
44.8%

FLS: Capital Markets Day And Leadership Change Will Shape Balanced Risk Reward

The analyst price target for FLSmidth has shifted slightly as analysts weigh mixed Q3 results against upcoming catalysts, including a capital markets day in March. Recent target moves have ranged from DKK 505 to DKK 580.
ZEAL
DKK 407.30
Zealand Pharma
7D
-4.0%
1Y
-41.8%

ZEAL: Metabolic Collaboration Will Support Future Upside Despite Trimmed Fair Value

Analysts have trimmed their price target on Zealand Pharma to approximately $746 from about $774, citing a slightly higher discount rate and revenue growth headwinds, partially offset by a modestly improved profit margin and a higher assumed future P/E multiple. What's in the News OTR Therapeutics and Zealand Pharma A/S entered into a multi program collaboration and license agreement to discover and develop therapeutics for metabolic diseases, combining Zealand Pharma's obesity and metabolic health expertise with OTR Therapeutics' R&D platform (Key Developments).
MAERSK B
DKK 14,955.00
A.P. Møller - Mærsk
7D
-1.0%
1Y
41.4%

MAERSK B: Freight Cycle Uncertainty Will Meet Mixed Margin And Earnings Outlook

Analysts have lifted their fair value estimate for A.P. Møller Mærsk from DKK 15,558 to about DKK 15,882, reflecting updated assumptions on revenue growth, profit margins and future P/E multiples in light of recent target moves, which range from DKK 8,600 to DKK 14,352 across the Street. Analyst Commentary Recent Street research on A.P. Møller Mærsk shows a wide spread in target prices, with several bullish analysts focusing on potential upside scenarios while others remain cautious.
ROCK B
DKK 211.00
Rockwool
7D
-6.2%
1Y
-15.7%

There's No Escaping Rockwool A/S' (CPH:ROCK B) Muted Earnings

Jan 10
There's No Escaping Rockwool A/S' (CPH:ROCK B) Muted Earnings
COLO B
DKK 576.80
Coloplast
7D
2.3%
1Y
-27.6%

COLO B: Sustained Margins And Dividend Payouts Will Support Future Upside

Narrative update The analyst price target for Coloplast has edged up by about DKK 0.30 to reflect slightly higher fair value estimates. Recent Street research shows a mix of views, with some analysts lifting targets toward DKK 535 and others resetting them closer to DKK 640, which has led to modest adjustments to discount rate, revenue growth, profit margin, and future P/E assumptions.
GUBRA
DKK 460.00
Gubra
7D
-11.7%
1Y
-32.6%
DANSKE
DKK 323.50
Danske Bank
7D
2.9%
1Y
51.8%

DANSKE: Future Returns Will Reflect Earnings Durability And Easing Legal Overhang

Analysts have nudged their fair value estimate for Danske Bank up from DKK 308 to DKK 310, reflecting a series of recent price target increases (including moves to DKK 295 and DKK 319) and small adjustments in discount rate, profit margin and forward P/E assumptions. Analyst Commentary Recent research on Danske Bank has centered on a cluster of price target revisions, with several large firms updating their views within a short period.
DEMANT
DKK 231.20
Demant
7D
4.8%
1Y
-18.4%

DEMANT: Future Earnings Resilience Will Rely On Stable Market Position

Analysts have trimmed their price target on Demant slightly from DKK 271.65 to DKK 268. This reflects modestly softer assumptions for revenue growth and future P/E, partly offset by a marginally higher expected profit margin and recent views that organic revenue share gains may be limited for now.
VWS
DKK 186.10
Vestas Wind Systems
7D
2.7%
1Y
96.1%

VWS: Future Execution Risks May Undermine Raised Outlook And Earnings Guidance

Analysts lifted their price target on Vestas Wind Systems to DKK 173 from DKK 164, citing updated assumptions on fair value, discount rate, revenue growth, profit margin and future P/E that support a slightly higher long term outlook for the shares. Analyst Commentary Bullish Takeaways Bullish analysts frame the new DKK 173 target as reflecting updated views on fair value that they see as better aligned with the company’s longer term earnings potential.
NSIS B
DKK 422.10
Novozymes
7D
3.1%
1Y
4.6%